[Summary] A company providing raw materials for in vitro diagnostic reagent prod
Hangzhou Huadesen Biotechnology Co., Ltd. is a National High-Tech Enterprise, a Zhejiang Provincial Science and Technology Enterprise, a high-growth "Gazelle Enterprise" of Hangzhou High-Tech Zone, a key supported enterprise under Hangzhou's "Falcon Plan" for science and technology enterprises, and has successfully been shortlisted as a "2020 China Health New Force Enterprise" solicited by People's Daily Online. The company's "Hangzhou Huadesen Precision Medicine Testing Technology R&D Center" has been certified as a Zhejiang Provincial High-Tech Enterprise Research and Development Center and a Hangzhou Municipal Enterprise High-Tech Research and Development Center.
The Huadesen CytoSorter® CTC integrated detection system provides precise, reliable, real-time, and non-invasive overall solutions for cancer patients and high-risk populations. It enables early cancer screening, efficacy monitoring, and prognostic assessment, and can also predict cancer recurrence and metastasis, assisting in the selection of medication regimens for cancer patients. The CytoSorter® epithelial-mesenchymal typing kit is a product for highly sensitive capture and detection of epithelial-type, mesenchymal-type, and epithelial-mesenchymal mixed-type CTCs in peripheral blood. Based on advanced patented microfluidic nanochip technology, it uses dual antibodies EpCAM and CSV to capture CTCs and CTMs of various subtypes, and employs PanCK antibody, CSV antibody, and CD45 antibody for identification, overcoming the capture and identification challenges caused by CTC heterogeneity and rarity and reducing the missed detection rate. It is a powerful tool for real-time tracking and monitoring of tumor disease progression. The Huadesen® CTC PD-L1 detection kit adopts advanced patented herringbone-structured nano-microfluidic chip technology for fully automated CTC scanning and detection. It uses dual antibodies EpCAM and CSV for capture and three antibodies PanCK, CSV, and PD-L1 for detection, simultaneously achieving specific subtype capture and counting of various CTCs and CTC PD-L1 detection. It can be used to assist in real-time assessment of treatment efficacy and prognostic evaluation, providing an important basis for clinical medication guidance, disease progression monitoring, and efficacy judgment.
The company has strong technical strength. Under the collaborative guidance of several academicians and experts such as "*" at home and abroad, it has an R&D team of dozens of doctoral and master's degree holders. The company emphasizes independent innovation and owns multiple invention patents for new technologies and software copyrights.
The company operates a "Precision Medicine Testing Center" and a "CTC Testing Joint Laboratory," forming a comprehensive service platform integrating clinical testing services, scientific research, and development. The company is committed to precision testing and individualized medication guidance services, striving to become an important partner for clinical medical institutions and research institutes.
What does Hangzhou Huadesen Biotechnology Co., Ltd. require? Who is Huadesen Biotech hiring? Huadesen Biotech recruitment: Biology/Pharmaceutical/Chemical/Environmental Protection占比最多占35.3%，其次是Other (R&D and Technical)占29.4%. What education can get in at Huadesen Biotech? 本科占比最多占41.2%，其次是硕士占29.4%. High education required at Huadesen Biotech? 硕士占29.4%，博士占2.9%. Work experience required at Huadesen Biotech? 5-10年占比最多占38.2%，其次是不限占38.2%. Where are the job locations at Huadesen Biotech? 杭州占比最多占76.5%，其次是上海占5.9%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
